COMMUNIQUÉS West-GlobeNewswire

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
24/04/2025
Presentations underscore long-term clinical outcomes, safety and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System demonstrations SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE [...]
Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor
24/04/2025
► Biomarker signatures were developed to predict histological treatment response to lanifibranor treatment in patients with MASH and fibrosis ► The biomarker signatures developed for fibrosis improvement, MASH [...]
Inventiva annonce la publication dans Clinical Gastroenterology and Hepatology de l’analyse de nouvelles signatures de biomarqueurs prédictives de la réponse histologique chez les patients atteints de MASH traités par lanifibranor
24/04/2025
► Des signatures de biomarqueurs ont été développées pour prédire la réponse histologique au traitement par lanifibranor chez les patients atteints de MASH avec fibrose ► Les signatures de biomarqueurs développées pour [...]
Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025
24/04/2025
LONDON, April 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 29, 2025 at 8:30 a.m. Eastern [...]
Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025
24/04/2025
COPENHAGEN, Denmark, April 24, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter 2025 financial results and provide a business update on Thursday, May 1, 2025, [...]
Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
24/04/2025
Interpace Expects to Remain Profitable as a Thyroid-focused Business PARSIPPANY, NJ, April 24, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics ® , a subsidiary of Interpace Biosciences ® , (“Interpace” or the “Company [...]
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report
24/04/2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building, will report its financial results for the quarterly period ended March 31, 2025, after [...]
May is Brain Cancer Awareness Month: Illuminate the Fight Against One of the Most Lethal Cancers
24/04/2025
TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- This May, Brain Cancer Canada (BCC) and communities across the country prepare to rally for Brain Cancer Awareness Month. Dedicated to supporting those impacted by brain [...]
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025
24/04/2025
RIDGE is Largest Natural History Study Conducted with More Than 175 Participants Enrolled to Date with Arrhythmogenic Right Ventricular Cardiomyopathy Due to Mutations in the PKP2 Gene Patients Experience High Burden of [...]
Faraday Pharmaceuticals to Host Satellite Symposium at SCAI 2025 on Exploring New Frontiers in Reducing Ischemia-Reperfusion Injury
24/04/2025
SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial [...]
Imprivata Names Joel Burleson-Davis as Chief Technology Officer
24/04/2025
Experienced leader and technology visionary to accelerate innovation at Imprivata to help customers solve pressing access management, security, and workflow challenges WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- [...]
Clariane I 2025 first-quarter revenue
24/04/2025
Press release Revenue for the three months to 31 March 2025 rose by 4.8% on an organic basis, which equates to a 5.5% increase on a comparable number of days. All businesses and regions contributed to revenue growth , [...]
Clariane I Chiffre d’affaires au 31 mars 2025
24/04/2025
Communiqué de presse Le chiffre d’affaires au 31 mars 2025 progresse en base organique de +4,8%, ce qui correspond à une croissance de + 5,5% à nombre de jours comparable L’ensemble des activités et des régions [...]
Best Kratom for Energy: Top Strains Recommended by Happy Go Leafy
24/04/2025
Searching for the best kratom for energy strains? Go to Happy Go Leafy’s official website and find the best options available. Enjoy premium pricing & discounts! Miami, Florida, April 24, 2025 (GLOBE NEWSWIRE) -- [...]
Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million
24/04/2025
Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million Halle (Saale) / Munich, Germany, April 24, 2025 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (“ Vivoryon ” or the “ [...]
SAFE Group signe un accord de distribution au Venezuela et annonce le succès de la première chirurgie
24/04/2025
SAFE Group signe un accord de distribution au Venezuela et annonce le succès de la première chirurgie Fleurieux-sur-l’Arbresle - France - le 24 avril 2025 à 18h . Safe SA (la « Société ») est fière d'annoncer la [...]
Guerbet: Q1 2025 revenue
24/04/2025
Q1 2025 revenue Quarterly activity Revenue: €180.1m, down 7.1% at CER 1 and on a like-for-like basis 2 As expected, a first quarter marked by a persistent impact on France and a penalizing base effect Declining momentum [...]
GUERBET: Chiffre d’affaires du 1er trimestre 2025
24/04/2025
Chiffre d’affaires du 1 er trimestre 2025 Activité trimestrielle Chiffre d’affaires : 180,1 M€, en repli de 7,1% à TCC 1 et périmètre comparable 2 Comme anticipé, un premier trimestre marqué par un impact France [...]
Koelis annonce un partenariat avec Bot Image™ lors du congrès de l’AUA 2025
24/04/2025
Une nouvelle technologie d’IA pour améliorer la précision des biopsies de la prostate et l’efficacité des procédures GRENOBLE, France et PRINCETON, New Jersey, 24 avr. 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (« Koelis » ou [...]

Pages